Abstract

The advantages of arthroplasty include maintenance of motion, avoiding nonunions, and avoiding plate and screw complications such as backout, esophageal erosion, and periplate ossification. Thus far, the purported long-term benefit of reducing the incidence of adjacent segment pathology has not been born out in FDA-IDE trials reporting on up to 5-year results. Only one disc showed a difference. There is, however, some unpublished data that suggests that at > 5 years, another arthroplasty has benefits over ACDF. In this study, I will review the available data. Disclosure of Interest None declared

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.